These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31299989)

  • 1. Plasma YKL-40 in the spectrum of neurodegenerative dementia.
    Villar-Piqué A; Schmitz M; Hermann P; Goebel S; Bunck T; Varges D; Ferrer I; Riggert J; Llorens F; Zerr I
    J Neuroinflammation; 2019 Jul; 16(1):145. PubMed ID: 31299989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma total prion protein as a potential biomarker for neurodegenerative dementia: diagnostic accuracy in the spectrum of prion diseases.
    Llorens F; Villar-Piqué A; Schmitz M; Diaz-Lucena D; Wohlhage M; Hermann P; Goebel S; Schmidt I; Glatzel M; Hauw JJ; Sikorska B; Liberski PP; Riggert J; Ferrer I; Zerr I
    Neuropathol Appl Neurobiol; 2020 Apr; 46(3):240-254. PubMed ID: 31216593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease.
    Zerr I; Villar-Piqué A; Hermann P; Schmitz M; Varges D; Ferrer I; Riggert J; Zetterberg H; Blennow K; Llorens F
    Alzheimers Res Ther; 2021 Apr; 13(1):86. PubMed ID: 33883011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias.
    Antonell A; Tort-Merino A; Ríos J; Balasa M; Borrego-Écija S; Auge JM; Muñoz-García C; Bosch B; Falgàs N; Rami L; Ramos-Campoy O; Blennow K; Zetterberg H; Molinuevo JL; Lladó A; Sánchez-Valle R
    Alzheimers Dement; 2020 Feb; 16(2):262-272. PubMed ID: 31668967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting.
    Kokkinou M; Beishon LC; Smailagic N; Noel-Storr AH; Hyde C; Ukoumunne O; Worrall RE; Hayen A; Desai M; Ashok AH; Paul EJ; Georgopoulou A; Casoli T; Quinn TJ; Ritchie CW
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD010945. PubMed ID: 33566374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias.
    Llorens F; Thüne K; Tahir W; Kanata E; Diaz-Lucena D; Xanthopoulos K; Kovatsi E; Pleschka C; Garcia-Esparcia P; Schmitz M; Ozbay D; Correia S; Correia Â; Milosevic I; Andréoletti O; Fernández-Borges N; Vorberg IM; Glatzel M; Sklaviadis T; Torres JM; Krasemann S; Sánchez-Valle R; Ferrer I; Zerr I
    Mol Neurodegener; 2017 Nov; 12(1):83. PubMed ID: 29126445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia.
    Abu-Rumeileh S; Steinacker P; Polischi B; Mammana A; Bartoletti-Stella A; Oeckl P; Baiardi S; Zenesini C; Huss A; Cortelli P; Capellari S; Otto M; Parchi P
    Alzheimers Res Ther; 2019 Dec; 12(1):2. PubMed ID: 31892365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.
    Grangeon L; Paquet C; Bombois S; Quillard-Muraine M; Martinaud O; Bourre B; Lefaucheur R; Nicolas G; Dumurgier J; Gerardin E; Jan M; Laplanche JL; Peoc'h K; Hugon J; Pasquier F; Maltête D; Hannequin D; Wallon D;
    J Alzheimers Dis; 2016; 51(3):905-13. PubMed ID: 26890785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CSF Ubiquitin Levels Are Higher in Alzheimer's Disease than in Frontotemporal Dementia and Reflect the Molecular Subtype in Prion Disease.
    Abu-Rumeileh S; Oeckl P; Baiardi S; Halbgebauer S; Steinacker P; Capellari S; Otto M; Parchi P
    Biomolecules; 2020 Mar; 10(4):. PubMed ID: 32218217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Biomarkers in Neurodegenerative Dementias: Unrevealing the Potential of Serum Oxytocin, BDNF, NPTX1, TREM2, TNF-alpha, IL-1 and Prolactin.
    Olğun Y; Poyraz CA; Bozluolçay M; Konukoğlu D; Poyraz BÇ
    Curr Alzheimer Res; 2024; 21(2):109-119. PubMed ID: 38803182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases.
    Zerr I; Schmitz M; Karch A; Villar-Piqué A; Kanata E; Golanska E; Díaz-Lucena D; Karsanidou A; Hermann P; Knipper T; Goebel S; Varges D; Sklaviadis T; Sikorska B; Liberski PP; Santana I; Ferrer I; Zetterberg H; Blennow K; Calero O; Calero M; Ladogana A; Sánchez-Valle R; Baldeiras I; Llorens F
    Alzheimers Dement; 2018 Jun; 14(6):751-763. PubMed ID: 29391125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease.
    Baldacci F; Toschi N; Lista S; Zetterberg H; Blennow K; Kilimann I; Teipel S; Cavedo E; Dos Santos AM; Epelbaum S; Lamari F; Dubois B; Floris R; Garaci F; Bonuccelli U; Hampel H
    Alzheimers Dement; 2017 Sep; 13(9):993-1003. PubMed ID: 28263742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodegeneration and Glial Activation Related CSF Biomarker as the Diagnosis of Alzheimer's Disease: A Systematic Review and an Updated Meta- analysis.
    Hao Y; Liu X; Zhu R
    Curr Alzheimer Res; 2022; 19(1):32-46. PubMed ID: 34879804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuroinflammatory biomarker YKL-40 for neurodegenerative diseases: advances in development.
    Baldacci F; Lista S; Palermo G; Giorgi FS; Vergallo A; Hampel H
    Expert Rev Proteomics; 2019 Jul; 16(7):593-600. PubMed ID: 31195846
    [No Abstract]   [Full Text] [Related]  

  • 15. The Inflammatory Marker YKL-40 Is Elevated in Cerebrospinal Fluid from Patients with Alzheimer's but Not Parkinson's Disease or Dementia with Lewy Bodies.
    Wennström M; Surova Y; Hall S; Nilsson C; Minthon L; Hansson O; Nielsen HM
    PLoS One; 2015; 10(8):e0135458. PubMed ID: 26270969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease.
    Janelidze S; Hertze J; Zetterberg H; Landqvist Waldö M; Santillo A; Blennow K; Hansson O
    Ann Clin Transl Neurol; 2016 Jan; 3(1):12-20. PubMed ID: 26783546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum brain-derived neurotrophic factor levels in different neurological diseases.
    Ventriglia M; Zanardini R; Bonomini C; Zanetti O; Volpe D; Pasqualetti P; Gennarelli M; Bocchio-Chiavetto L
    Biomed Res Int; 2013; 2013():901082. PubMed ID: 24024214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Matrix Metalloproteinase-2 (MMP-2) and -9 (MMP-9) and Their Tissue Inhibitors (TIMP-1 and TIMP-2) in Plasma from Patients with Neurodegenerative Dementia.
    Tuna G; Yener GG; Oktay G; İşlekel GH; Kİrkalİ FG
    J Alzheimers Dis; 2018; 66(3):1265-1273. PubMed ID: 30412498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurofilament light chain protein in neurodegenerative dementia: A systematic review and network meta-analysis.
    Zhao Y; Xin Y; Meng S; He Z; Hu W
    Neurosci Biobehav Rev; 2019 Jul; 102():123-138. PubMed ID: 31026486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients.
    Van Everbroeck B; Dobbeleir I; De Waele M; De Deyn P; Martin JJ; Cras P
    J Neurol; 2004 Mar; 251(3):298-304. PubMed ID: 15015009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.